Carnegie Mellon University.
Am Psychol. 2017 Feb-Mar;72(2):118-125. doi: 10.1037/a0040438.
The U.S. Food and Drug Administration (FDA) regulates products accounting for 20% of U.S. consumer spending. Many of its actions depend on assumptions about behavior. Will people heed food recall notices? Will they follow medication schedules? Will they have realistic expectations regarding the benefits and risks of new products? Over time, FDA has increasingly made psychology integral to its processes for answering such questions. That progress has come when windows of opportunity have found psychologists with science relevant to FDA's needs, FDA with staff who can translate that research into agency terms, and a regulatory arena that can accommodate behavioral evidence. These experiences suggest opportunities and obstacles for psychologists hoping to apply their science to the public good. (PsycINFO Database Record
美国食品和药物管理局（FDA）监管着占美国消费者支出 20%的产品。其许多行动都依赖于对行为的假设。人们会关注食品召回通知吗？他们会按照药物时间表服药吗？他们对新产品的益处和风险会有合理的期望吗？随着时间的推移，FDA 越来越多地将心理学纳入其回答此类问题的过程中。当机会之窗为 FDA 找到具有相关科学知识的心理学家、为 FDA 找到能够将该研究转化为机构术语的工作人员以及为监管领域找到能够容纳行为证据的机会时，这种进展就出现了。这些经验为希望将其科学应用于公益事业的心理学家提供了机会和障碍。（PsycINFO 数据库记录）
